Log in
Enquire now

List of MyoKardia patents

List of MyoKardia patents
List of Cascade Engineering patents
List of United Airlines patents
List of Flow International Corporation patents
Companies in the Impact investing industry
List of funding rounds for Azincourt Energy Corp.
Patents where
Current Assignee
Name
is
MyoKardiaMyoKardia
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9663516 Bicyclic-pyrimidinedione compounds

Patent 9663516 was granted and assigned to MyoKardia on May, 2017 by the United States Patent and Trademark Office.

MyoKardia
MyoKardia
MyoKardia
MyoKardia
United States Patent and Trademark Office
United States Patent and Trademark Office
9663516
May 30, 2017
‌
US Patent 9925177 4-methylsulfonyl-substituted piperidine urea compounds

Patent 9925177 was granted and assigned to MyoKardia on March, 2018 by the United States Patent and Trademark Office.

MyoKardia
MyoKardia
MyoKardia
MyoKardia
United States Patent and Trademark Office
United States Patent and Trademark Office
9925177
March 27, 2018
‌
US Patent 9181200 Pyrimidinedione compounds

Patent 9181200 was granted and assigned to MyoKardia on November, 2015 by the United States Patent and Trademark Office.

MyoKardia
MyoKardia
MyoKardia
MyoKardia
United States Patent and Trademark Office
United States Patent and Trademark Office
9181200
November 10, 2015
‌
US Patent 9199945 Cycloalkyl-substituted pyrimidinedione compounds

Patent 9199945 was granted and assigned to MyoKardia on December, 2015 by the United States Patent and Trademark Office.

MyoKardia
MyoKardia
MyoKardia
MyoKardia
United States Patent and Trademark Office
United States Patent and Trademark Office
9199945
December 1, 2015
‌
US Patent 11123337 4-methylsulfonyl-substituted piperidine urea compounds

Patent 11123337 was granted and assigned to MyoKardia on September, 2021 by the United States Patent and Trademark Office.

MyoKardia
MyoKardia
MyoKardia
MyoKardia
United States Patent and Trademark Office
United States Patent and Trademark Office
11123337
September 21, 2021
‌
US Patent 11034693 Substituted 5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-2,4-diones for treating cardiac diseases

Patent 11034693 was granted and assigned to MyoKardia on June, 2021 by the United States Patent and Trademark Office.

MyoKardia
MyoKardia
MyoKardia
MyoKardia
United States Patent and Trademark Office
United States Patent and Trademark Office
11034693
June 15, 2021
‌
US Patent 9585883 Pyrimidinedione compounds

Patent 9585883 was granted and assigned to MyoKardia on March, 2017 by the United States Patent and Trademark Office.

MyoKardia
MyoKardia
MyoKardia
MyoKardia
United States Patent and Trademark Office
United States Patent and Trademark Office
9585883
March 7, 2017
‌
US Patent 10758525 4-methylsulfonyl-substituted piperidine urea compounds

MyoKardia
MyoKardia
MyoKardia
MyoKardia
United States Patent and Trademark Office
United States Patent and Trademark Office
10758525
September 1, 2020
‌
US Patent 11873289 Pyrazole compounds and preparation thereof

Patent 11873289 was granted and assigned to MyoKardia on January, 2024 by the United States Patent and Trademark Office.

MyoKardia
MyoKardia
MyoKardia
MyoKardia
United States Patent and Trademark Office
United States Patent and Trademark Office
11873289
January 16, 2024
9 results
0 selected
9 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us